Overview
The Anti-RANKL/Osteoprotegerin (OPG) Rabbit Polyclonal Antibody is a high-specificity, unconjugated antibody designed to detect OPG (TNFRSF11B), a key decoy receptor in the RANKL signaling pathway. Validated across multiple applications including Western Blot, ELISA, Immunohistochemistry, and Immunofluorescence, this antibody is essential for research in bone remodeling, osteoclastogenesis, cancer biology, and inflammatory diseases.
Background
Osteoprotegerin (OPG) acts as a decoy receptor for RANKL, inhibiting osteoclast differentiation and activity. It plays a critical role in bone homeostasis, vascular calcification, and immune regulation. Dysregulation of the OPG/RANKL axis is associated with osteoporosis, arthritis, metastatic bone disease, and cardiovascular disorders.
Research Applications
Ideal for:
-
Bone remodeling and osteoclastogenesis studies
-
Cancer-induced bone disease and metastasis research
-
Cardiovascular calcification and arterial stiffness analysis
-
Autoimmune and inflammatory condition models
-
Drug development for metabolic bone disorders
Pathways Involved
NF-kappaB signaling, bone homeostasis, apoptosis regulation.
Note: For research use only. Not for diagnostic or therapeutic use.
Reviews
There are no reviews yet.